Based at the Paterson Institute for Cancer Research within The University of Manchester’s School of Cancer and Enabling Sciences, the recently established CIMML is at the front line of the UK’s fight against cancer, facilitating potentially life-changing translational research and early clinical trials across a wide spectrum of cancer research.

To show they achieved compliance with the relative industry standards, CIMML needed a flexible system to easily manage their document, asset, audit and training records in line with the MHRA regulated Good Clinical Laboratory Practice (GCLP) and their funding body Cancer Research UK.

Q-Pulse, developed by Gael Ltd, was chosen as being the most effective and simple solution to manage their compliance activities.

Dr Dominic Rothwell, Head of the Laboratory, said: “We first saw Q-Pulse and the many benefits it brought when in use at the Blood Transfusion service. They were doing some work in partnership with us and we thought it would make sense for us both to have the same system.

“Since implementing Q-Pulse we’ve found it much easier and cost effective to manage our compliance activities to the relevant regulatory requirements.

“By being able to log and capture all our document information electronically in one central place has resulted in a more streamlined method of document management. The Audit, Training and Asset modules allow us to keep on top of staff training records - assessing them against our SOPs - as well as being able to easily manage our internal and external audits and assets.”

The CIMML facility is currently involved in a wide range of clinical trials and pioneering translational research projects including immune-based therapies and the development of molecular markers for use in personalised medicine approaches. Having a simple, efficient and reliable electronic compliant system is essential to be able to bring these novel technologies and therapies to a wider clinical base outside of specialised research centres and allow the rapid integration of new projects within the laboratory.

Dr Rothwell added: “If we didn’t have Q-Pulse a lot more of our time would be spent administering our compliance issues rather than being spent in the laboratory, we now have more time to focus on our clinical trials than we did previously.”